AIRLINK 78.39 Increased By ▲ 5.39 (7.38%)
BOP 5.32 Decreased By ▼ -0.03 (-0.56%)
CNERGY 4.32 Increased By ▲ 0.01 (0.23%)
DFML 30.87 Increased By ▲ 2.32 (8.13%)
DGKC 77.99 Increased By ▲ 3.70 (4.98%)
FCCL 20.63 Increased By ▲ 0.28 (1.38%)
FFBL 32.15 Increased By ▲ 1.25 (4.05%)
FFL 10.22 Increased By ▲ 0.16 (1.59%)
GGL 10.29 Decreased By ▼ -0.10 (-0.96%)
HBL 117.99 Increased By ▲ 2.02 (1.74%)
HUBC 135.00 Increased By ▲ 2.80 (2.12%)
HUMNL 6.79 Increased By ▲ 0.11 (1.65%)
KEL 4.15 Increased By ▲ 0.12 (2.98%)
KOSM 4.74 Increased By ▲ 0.14 (3.04%)
MLCF 38.94 Increased By ▲ 0.40 (1.04%)
OGDC 134.15 Increased By ▲ 0.30 (0.22%)
PAEL 23.44 Decreased By ▼ -0.39 (-1.64%)
PIAA 26.90 Decreased By ▼ -0.23 (-0.85%)
PIBTL 7.01 Increased By ▲ 0.25 (3.7%)
PPL 113.29 Increased By ▲ 0.49 (0.43%)
PRL 27.78 Decreased By ▼ -0.38 (-1.35%)
PTC 14.60 Decreased By ▼ -0.29 (-1.95%)
SEARL 56.48 Increased By ▲ 0.06 (0.11%)
SNGP 66.10 Increased By ▲ 0.30 (0.46%)
SSGC 10.95 Decreased By ▼ -0.06 (-0.54%)
TELE 9.19 Increased By ▲ 0.17 (1.88%)
TPLP 11.70 Decreased By ▼ -0.20 (-1.68%)
TRG 71.72 Increased By ▲ 2.62 (3.79%)
UNITY 24.05 Increased By ▲ 0.34 (1.43%)
WTL 1.33 No Change ▼ 0.00 (0%)
BR100 7,502 Increased By 67.3 (0.91%)
BR30 24,568 Increased By 348.6 (1.44%)
KSE100 72,055 Increased By 695.5 (0.97%)
KSE30 23,809 Increased By 242.6 (1.03%)
Pakistan

Novartis donates RS41.25mn to PRCS for the fight against COVID-19 pandemic

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas m
Published May 7, 2020
  • Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Novartis donated PKR 41.25 Million to Pakistan Red Crescent Society (PRCS), one of the largest humanitarian organizations in the country to support in efforts against COVID-19.

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Dr. Imran Rasheed, Chief Executive Officer, Novartis Pharma Pakistan, said, “Novartis Pakistan feels proud to stand with our Healthcare Professionals at their hour of need and hope to mitigate and contain this deadly infection as soon as humanly possible. Novartis has always remained on the forefront when it comes to Corporate Social Responsibility.

In Pakistan, we have ongoing projects in collaboration with government, NGOs and other partners working actively for the benefits of patients. We have the biggest Oncology Access program in Pakistan, providing cancer medicines free of cost, worth billions of rupees. During this challenging time of COVID-19 Pandemic, with this donation, Novartis contributing back to the society is core to our strategy and one of the pillars of Novartis vision”.

Comments

Comments are closed.